Zhi Yao

机构：Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University · ORCID：0000-0001-8472-0731

发表论文 325 篇 · 总被引 13500 次 · h-index 64

代表论文

• Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity (2023 · Immunity · 被引 79)
• A di-acetyl-decorated chromatin signature couples liquid condensation to suppress DNA end synapsis (2024 · Molecular Cell · 被引 24)
• Maternal antibiotic exposure enhances ILC2 activation in neonates via downregulation of IFN1 signaling (2023 · Nature Communications · 被引 23)
• EGC enhances tumor antigen presentation and CD8+ T cell-mediated antitumor immunity via targeting oncoprotein SND1 (2024 · Cancer Letters · 被引 15)
• Targeting the BCKDK/BCLAF1/MYC/HK2 axis to alter aerobic glycolysis and overcome Trametinib resistance in lung cancer (2025 · Cell Death and Differentiation · 被引 14)
• Photodynamic Immunotherapy Using ADU-S100-Modified Nanoparticles to Treat Triple-Negative Breast Cancer (2023 · Nanomedicine · 被引 9)